Brief: PAION U.S. License Agreement For BYFAVOTM Between Paion And Cosmo
July 15 (Reuters) - PAION AG PA8G.DE :
* U.S. LICENSE AGREEMENT FOR BYFAVOTM (REMIMAZOLAM) BETWEEN
PAION
AND COSMO ASSIGNED FROM COSMO TO ACACIA
* PAION AG - TERMS OF LICENSE AGREEMENT REMAIN UNCHANGED BUT
WILL
NOW BE BETWEEN PAION AND ACACIA, WITH COSMO NO LONGER BEING A
PARTY TO AGREEMENT.
Source text for Eikon: ID:nEQbLjjLGa
Further company coverage: PA8G.DE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;;))
Recent news on Cosmo NV
See all newsFocus: Beyond the Scale: Men turn to cosmetic clinics to complete weight-loss transformation
Ireland's Cosmo recurring revenue rises on winlevi growth, reaffirms FY guidance
Brief: Cosmo Pharmaceuticals H1 EPS EUR -0.279
Cosmo Pharma's male hair loss treatment shows sustained hair growth in year‑long study
Europe Research Roundup: Airbus ,Bechtle, Salzgitter